SunnyRainbow personal page - To The Moon

SunnyRainbow

SunnyRainbow

No personal profile

74Follow

5Followers

2Topic

0Badge

2023-03-03

[Eye]

@MaverickWealthBuilder:Would iQiyi be the next Netflix in Stock Market?

2023-02-05

Market cap, ROE, Dividend yield, pe for fundamental

2022-11-06

[Eye]

Sorry, the original content has been removed

2022-10-29

$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$

2022-10-25

Health Industry

@WallStreet_Tiger:Pharma Kings: LLY, MRK, VRTX, AMLX & IMRA Hit New Heights Again

2022-10-03

I would adjust and diversified my portfolio. Go for defensive stock.

2022-10-03

Thanks for sharing 💪🏻

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4118486717784542,"uuid":"4118486717784542","gmtCreate":1655387066005,"gmtModify":1677254993214,"name":"SunnyRainbow","pinyin":"sunnyrainbow","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":74,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":13,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":"60.35%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9940611120,"gmtCreate":1677857957061,"gmtModify":1677857960619,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Eye]&nbsp;","listText":"[Eye]&nbsp;","text":"[Eye]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9940611120","repostId":"9957195111","repostType":1,"repost":{"id":9957195111,"gmtCreate":1677068611934,"gmtModify":1677068623071,"author":{"id":"4102740236684050","authorId":"4102740236684050","name":"MaverickWealthBuilder","avatar":"https://community-static.tradeup.com/news/bbf0f514b8e5abb92266789b89f6e1e6","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Would iQiyi be the next Netflix in Stock Market?","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IQ\"></a><a href=\"https://ttm.financial/S/IQ\">$iQiyi Inc.(IQ)$</a>&nbsp;released 22Q4 and&nbsp;the whole year financial report, an&nbsp;unexpected profit and greaterly&nbsp;improving free cash flow should&nbsp;send&nbsp;it&nbsp;to&nbsp;another&nbsp;YTD&nbsp;high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IQ\"></a><a href=\"https://ttm.financial/S/IQ\">$iQiyi Inc.(IQ)$</a>&nbsp;released 22Q4 and&nbsp;the whole year financial report, an&nbsp;unexpected profit and greaterly&nbsp;improving free cash flow should&nbsp;send&nbsp;it&nbsp;to&nbsp;another&nbsp;YTD&nbsp;high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","text":"$iQiyi Inc.(IQ)$ released 22Q4 and the whole year financial report, an unexpected profit and greaterly improving free cash flow should send it to another YTD high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","images":[{"img":"https://static.tigerbbs.com/83dc65ff1ce5d4c16fc1991cc592b4df","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957195111","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955554366,"gmtCreate":1675606780555,"gmtModify":1676539009031,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Market cap, ROE, Dividend yield, pe for fundamental&nbsp;","listText":"Market cap, ROE, Dividend yield, pe for fundamental&nbsp;","text":"Market cap, ROE, Dividend yield, pe for fundamental","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955554366","isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9984780737,"gmtCreate":1667742830529,"gmtModify":1676537957879,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Eye]&nbsp;","listText":"[Eye]&nbsp;","text":"[Eye]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984780737","repostId":"2281568031","repostType":4,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9986750205,"gmtCreate":1667021397807,"gmtModify":1676537851242,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$","images":[{"img":"https://community-static.tradeup.com/news/ffae5b6540aa85c7746bce0439212e7b","width":"1080","height":"1841"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9986750205","isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9988122680,"gmtCreate":1666700968340,"gmtModify":1676537792102,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Health Industry&nbsp;","listText":"Health Industry&nbsp;","text":"Health Industry","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9988122680","repostId":"9988121195","repostType":1,"repost":{"id":9988121195,"gmtCreate":1666700302818,"gmtModify":1676537791986,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://community-static.tradeup.com/news/1fdbba25bcf5dea3f281241ba1320d10","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Pharma Kings: LLY, MRK, VRTX, AMLX & IMRA Hit New Heights Again","htmlText":"Phamacy stocks rose 1.29% among S&amp;P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: <a target=\"_blank\" href=\"https://laohu8.com/S/AMLX\">$Amylyx Pharmaceuticals, Inc.(AMLX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$Imara Inc.(IMRA)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$Eli Lilly and(LLY)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>On Monday, <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$(IMRA)$</a> was up 15%,","listText":"Phamacy stocks rose 1.29% among S&amp;P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: <a target=\"_blank\" href=\"https://laohu8.com/S/AMLX\">$Amylyx Pharmaceuticals, Inc.(AMLX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$Imara Inc.(IMRA)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$Eli Lilly and(LLY)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>On Monday, <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$(IMRA)$</a> was up 15%,","text":"Phamacy stocks rose 1.29% among S&P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: $Amylyx Pharmaceuticals, Inc.(AMLX)$ , $Imara Inc.(IMRA)$ , $Vertex Pharmaceuticals(VRTX)$ , $Eli Lilly and(LLY)$ , $Merck(MRK)$On Monday, $(IMRA)$ was up 15%,","images":[{"img":"https://community-static.tradeup.com/news/b0c0095feeadf352629511126660a91a","width":"840","height":"470"},{"img":"https://community-static.tradeup.com/news/a2bb6ab1134f7a4648f57fead601cd52","width":"840","height":"470"},{"img":"https://community-static.tradeup.com/news/999d8586dc5cca0f73a4bb2bf9d6ba5f","width":"840","height":"470"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988121195","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":12,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9912837281,"gmtCreate":1664792786344,"gmtModify":1676537509145,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"I would adjust and diversified my portfolio. Go for defensive stock.","listText":"I would adjust and diversified my portfolio. Go for defensive stock.","text":"I would adjust and diversified my portfolio. Go for defensive stock.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912837281","isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9912834343,"gmtCreate":1664792419282,"gmtModify":1676537509102,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Thanks for sharing 💪🏻","listText":"Thanks for sharing 💪🏻","text":"Thanks for sharing 💪🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912834343","repostId":"1102930276","repostType":4,"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9986750205,"gmtCreate":1667021397807,"gmtModify":1676537851242,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>","listText":"<a href=\"https://ttm.financial/S/C8R.SI\">$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$</a>","text":"$JIUTIAN CHEMICAL GROUP LIMITED(C8R.SI)$","images":[{"img":"https://community-static.tradeup.com/news/ffae5b6540aa85c7746bce0439212e7b","width":"1080","height":"1841"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9986750205","isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9912834343,"gmtCreate":1664792419282,"gmtModify":1676537509102,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Thanks for sharing 💪🏻","listText":"Thanks for sharing 💪🏻","text":"Thanks for sharing 💪🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912834343","repostId":"1102930276","repostType":4,"repost":{"id":"1102930276","pubTimestamp":1664810461,"share":"https://www.laohu8.com/m/news/1102930276?lang=&edition=full","pubTime":"2022-10-03 23:21","market":"us","language":"en","title":"Credit Suisse CEO Seeks to Calm Markets as Default Swaps Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=1102930276","media":"Bloomberg","summary":"Credit Suisse Group AG’s new chief has asked investors for less than 100 days to deliver a new turna","content":"<html><head></head><body><p>Credit Suisse Group AG’s new chief has asked investors for less than 100 days to deliver a new turnaround strategy. Turbulent markets are making that feel like a long time.</p><p>The cost of insuring the firm’s bonds against default climbed about 15% last week to levels not seen since 2009 as the shares touched a new record low. On Friday, Chief Executive Officer Ulrich Koerner reassured staff that the bank has a “strong capital base and liquidity position” and told employees that he will be sending them a regular update until the firm announces a new strategic plan on Oct. 27.</p><p>Koerner, who was named CEO in late July, has had to deal with market speculation, banker exits and capital doubts as he seeks to set a path forward for the troubled Swiss bank. The lender is currently finalizing plans that will likely see sweeping changes to its investment bank and may include cutting thousands of jobs over a number of years, Bloomberg has reported.</p><p>Koerner’s memo was the second straight Friday missive as speculation over the beleaguered bank’s future increases. Analysts at KBW estimated that the firm may need to raise 4 billion Swiss francs ($4 billion) of capital even after selling some assets to fund any restructuring, growth efforts and any unknowns.</p><p>Credit Suisse’s market capitalization dropped to around 10 billion Swiss francs, meaning any share sale would be highly dilutive to longtime holders. The market value was above 30 billion francs as recently as March 2021.</p><p>Credit Suisse executives have noted that the firm’s 13.5% CET1 capital ratio at June 30 was in the middle of the planned range of 13% to 14% for 2022. The firm’s 2021 annual report said that its international regulatory minimum ratio was 8%, while Swiss authorities required a higher level of about 10%.</p><p><img src=\"https://static.tigerbbs.com/602188f35246305d577605208b99472b\" tg-width=\"698\" tg-height=\"392\" referrerpolicy=\"no-referrer\"/>The five-year credit default swaps price of about 250 basis points is up from about 55 basis points at the start of the year and is near their highest on record. While these levels are still far from distressed and are part of a broad market selloff, they signify deteriorating perceptions of creditworthiness for the scandal-hit bank in the current environment.</p><p>The KBW analysts were the latest to draw comparisons to the crisis of confidence that shook Deutsche Bank AG six years ago. Then, the German lender was facing broad questions about its strategy as well as near-term concerns about the cost of a settlement to end a US probe related to mortgage-backed securities. Deutsche Bank saw its credit-default swaps climb, its debt rating downgraded and some clients step back from working with it.</p><p>The stress eased over several months as the German firm settled for a lower figure than many feared, raised about 8 billion euros ($7.8 billion) of new capital and announced a strategy revamp. Still, what the bank called a “vicious circle” of declining revenue and rising funding costs took years to reverse.</p><p>There are differences between the two situations. Credit Suisse doesn’t face any one issue on the scale of Deutsche Bank’s $7.2 billion settlement, and its key capital ratio of 13.5% is higher than the 10.8% that the German firm had six years ago.</p><p>The stress Deutsche Bank faced in 2016 resulted in the unusual dynamic where the cost of insuring against losses on the lender’s debt for one year surpassed that of protection for five years. Credit Suisse’s one-year swaps are still significantly cheaper than five-year ones.</p><p>Last week, Credit Suisse said it’s working on possible asset and business sales as part of its strategic plan which will be unveiled at the end of October. The bank is exploring deals to sell its securitized products trading unit, is weighing the sale of its Latin American wealth management operations excluding Brazil, and is considering reviving the First Boston brand name, Bloomberg has reported.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Credit Suisse CEO Seeks to Calm Markets as Default Swaps Climb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCredit Suisse CEO Seeks to Calm Markets as Default Swaps Climb\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-10-02/credit-suisse-ceo-seeks-to-calm-as-default-swaps-near-2009-level><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Credit Suisse Group AG’s new chief has asked investors for less than 100 days to deliver a new turnaround strategy. Turbulent markets are making that feel like a long time.The cost of insuring the ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-10-02/credit-suisse-ceo-seeks-to-calm-as-default-swaps-near-2009-level\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2022-10-02/credit-suisse-ceo-seeks-to-calm-as-default-swaps-near-2009-level","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102930276","content_text":"Credit Suisse Group AG’s new chief has asked investors for less than 100 days to deliver a new turnaround strategy. Turbulent markets are making that feel like a long time.The cost of insuring the firm’s bonds against default climbed about 15% last week to levels not seen since 2009 as the shares touched a new record low. On Friday, Chief Executive Officer Ulrich Koerner reassured staff that the bank has a “strong capital base and liquidity position” and told employees that he will be sending them a regular update until the firm announces a new strategic plan on Oct. 27.Koerner, who was named CEO in late July, has had to deal with market speculation, banker exits and capital doubts as he seeks to set a path forward for the troubled Swiss bank. The lender is currently finalizing plans that will likely see sweeping changes to its investment bank and may include cutting thousands of jobs over a number of years, Bloomberg has reported.Koerner’s memo was the second straight Friday missive as speculation over the beleaguered bank’s future increases. Analysts at KBW estimated that the firm may need to raise 4 billion Swiss francs ($4 billion) of capital even after selling some assets to fund any restructuring, growth efforts and any unknowns.Credit Suisse’s market capitalization dropped to around 10 billion Swiss francs, meaning any share sale would be highly dilutive to longtime holders. The market value was above 30 billion francs as recently as March 2021.Credit Suisse executives have noted that the firm’s 13.5% CET1 capital ratio at June 30 was in the middle of the planned range of 13% to 14% for 2022. The firm’s 2021 annual report said that its international regulatory minimum ratio was 8%, while Swiss authorities required a higher level of about 10%.The five-year credit default swaps price of about 250 basis points is up from about 55 basis points at the start of the year and is near their highest on record. While these levels are still far from distressed and are part of a broad market selloff, they signify deteriorating perceptions of creditworthiness for the scandal-hit bank in the current environment.The KBW analysts were the latest to draw comparisons to the crisis of confidence that shook Deutsche Bank AG six years ago. Then, the German lender was facing broad questions about its strategy as well as near-term concerns about the cost of a settlement to end a US probe related to mortgage-backed securities. Deutsche Bank saw its credit-default swaps climb, its debt rating downgraded and some clients step back from working with it.The stress eased over several months as the German firm settled for a lower figure than many feared, raised about 8 billion euros ($7.8 billion) of new capital and announced a strategy revamp. Still, what the bank called a “vicious circle” of declining revenue and rising funding costs took years to reverse.There are differences between the two situations. Credit Suisse doesn’t face any one issue on the scale of Deutsche Bank’s $7.2 billion settlement, and its key capital ratio of 13.5% is higher than the 10.8% that the German firm had six years ago.The stress Deutsche Bank faced in 2016 resulted in the unusual dynamic where the cost of insuring against losses on the lender’s debt for one year surpassed that of protection for five years. Credit Suisse’s one-year swaps are still significantly cheaper than five-year ones.Last week, Credit Suisse said it’s working on possible asset and business sales as part of its strategic plan which will be unveiled at the end of October. The bank is exploring deals to sell its securitized products trading unit, is weighing the sale of its Latin American wealth management operations excluding Brazil, and is considering reviving the First Boston brand name, Bloomberg has reported.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9988122680,"gmtCreate":1666700968340,"gmtModify":1676537792102,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Health Industry&nbsp;","listText":"Health Industry&nbsp;","text":"Health Industry","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9988122680","repostId":"9988121195","repostType":1,"repost":{"id":9988121195,"gmtCreate":1666700302818,"gmtModify":1676537791986,"author":{"id":"9000000000000419","authorId":"9000000000000419","name":"WallStreet_Tiger","avatar":"https://community-static.tradeup.com/news/1fdbba25bcf5dea3f281241ba1320d10","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Pharma Kings: LLY, MRK, VRTX, AMLX & IMRA Hit New Heights Again","htmlText":"Phamacy stocks rose 1.29% among S&amp;P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: <a target=\"_blank\" href=\"https://laohu8.com/S/AMLX\">$Amylyx Pharmaceuticals, Inc.(AMLX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$Imara Inc.(IMRA)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$Eli Lilly and(LLY)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>On Monday, <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$(IMRA)$</a> was up 15%,","listText":"Phamacy stocks rose 1.29% among S&amp;P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: <a target=\"_blank\" href=\"https://laohu8.com/S/AMLX\">$Amylyx Pharmaceuticals, Inc.(AMLX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$Imara Inc.(IMRA)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/VRTX\">$Vertex Pharmaceuticals(VRTX)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$Eli Lilly and(LLY)$</a> , <a target=\"_blank\" href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>On Monday, <a target=\"_blank\" href=\"https://laohu8.com/S/IMRA\">$(IMRA)$</a> was up 15%,","text":"Phamacy stocks rose 1.29% among S&P 500 sectors on Monday, the third-highest gainer behind Systems Software (+1.82%) and Technology Hardware sectors (+1.44%).We have observed that several Healthcare stocks have been hitting new year highs recently: for example: $Amylyx Pharmaceuticals, Inc.(AMLX)$ , $Imara Inc.(IMRA)$ , $Vertex Pharmaceuticals(VRTX)$ , $Eli Lilly and(LLY)$ , $Merck(MRK)$On Monday, $(IMRA)$ was up 15%,","images":[{"img":"https://community-static.tradeup.com/news/b0c0095feeadf352629511126660a91a","width":"840","height":"470"},{"img":"https://community-static.tradeup.com/news/a2bb6ab1134f7a4648f57fead601cd52","width":"840","height":"470"},{"img":"https://community-static.tradeup.com/news/999d8586dc5cca0f73a4bb2bf9d6ba5f","width":"840","height":"470"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988121195","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":12,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9912837281,"gmtCreate":1664792786344,"gmtModify":1676537509145,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"I would adjust and diversified my portfolio. Go for defensive stock.","listText":"I would adjust and diversified my portfolio. Go for defensive stock.","text":"I would adjust and diversified my portfolio. Go for defensive stock.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912837281","isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9940611120,"gmtCreate":1677857957061,"gmtModify":1677857960619,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Eye]&nbsp;","listText":"[Eye]&nbsp;","text":"[Eye]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9940611120","repostId":"9957195111","repostType":1,"repost":{"id":9957195111,"gmtCreate":1677068611934,"gmtModify":1677068623071,"author":{"id":"4102740236684050","authorId":"4102740236684050","name":"MaverickWealthBuilder","avatar":"https://community-static.tradeup.com/news/bbf0f514b8e5abb92266789b89f6e1e6","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Would iQiyi be the next Netflix in Stock Market?","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IQ\"></a><a href=\"https://ttm.financial/S/IQ\">$iQiyi Inc.(IQ)$</a>&nbsp;released 22Q4 and&nbsp;the whole year financial report, an&nbsp;unexpected profit and greaterly&nbsp;improving free cash flow should&nbsp;send&nbsp;it&nbsp;to&nbsp;another&nbsp;YTD&nbsp;high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/IQ\"></a><a href=\"https://ttm.financial/S/IQ\">$iQiyi Inc.(IQ)$</a>&nbsp;released 22Q4 and&nbsp;the whole year financial report, an&nbsp;unexpected profit and greaterly&nbsp;improving free cash flow should&nbsp;send&nbsp;it&nbsp;to&nbsp;another&nbsp;YTD&nbsp;high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","text":"$iQiyi Inc.(IQ)$ released 22Q4 and the whole year financial report, an unexpected profit and greaterly improving free cash flow should send it to another YTD high?Q4 Performance ReviewRevenue was 7.59 billion yuan, a year-on-year increase of 2.8%, higher than the market expectation of 7.50 billion yuan;Among them, member service revenue was 4.7 billion yuan, a year-on-year increase of 15%; Advertising revenue was 1.55 billion yuan, down 7% year-on-year, higher than the market expectation of 1.39 billion yuan;Non-GAAP comparable earnings before interest and tax is 978 million yuan, and the profit rate reaches 13%, which is higher than the market ex","images":[{"img":"https://static.tigerbbs.com/83dc65ff1ce5d4c16fc1991cc592b4df","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957195111","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955554366,"gmtCreate":1675606780555,"gmtModify":1676539009031,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Market cap, ROE, Dividend yield, pe for fundamental&nbsp;","listText":"Market cap, ROE, Dividend yield, pe for fundamental&nbsp;","text":"Market cap, ROE, Dividend yield, pe for fundamental","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955554366","isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9984780737,"gmtCreate":1667742830529,"gmtModify":1676537957879,"author":{"id":"4118486717784542","authorId":"4118486717784542","name":"SunnyRainbow","avatar":"https://community-static.tradeup.com/news/5e5189e41310fc7d3eac20868453060c","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"[Eye]&nbsp;","listText":"[Eye]&nbsp;","text":"[Eye]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9984780737","repostId":"2281568031","repostType":4,"repost":{"id":"2281568031","pubTimestamp":1667701903,"share":"https://www.laohu8.com/m/news/2281568031?lang=&edition=full","pubTime":"2022-11-06 10:31","market":"us","language":"en","title":"7 Excellent Small-Cap Stocks to Buy Before This Year Ends","url":"https://stock-news.laohu8.com/highlight/detail?id=2281568031","media":"InvestorPlace","summary":"Some small-cap stocks tend to fly under the radar, but they still can deliver returns that rival any","content":"<html><head></head><body><ul><li>Some small-cap stocks tend to fly under the radar, but they still can deliver returns that rival any of their bigger-name competitors.</li><li><b><a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a></b> (<b><u>ENPH</u></b>): The California-based solar energy company consistently beats expectations in its quarterly earnings report.</li><li><b>Axcelis Technologies</b> (<b><u>ACLS</u></b>): Semiconductors will continue to be in great demand, which bodes well for Axcelis.</li><li><b>AMN Healthcare</b> (<b><u>AMN</u></b>): This company helps hospitals and healthcare facilities solve their staffing shortages.</li><li><b>Alpha and Omega Semiconductor</b> (<b><u>AOSL</u></b>): The stock is down so far in 2022, but it appears ripe for a turnaround.</li><li><b><a href=\"https://laohu8.com/S/ARLP\">Alliance Resource Partners</a></b> (<b><u>ARLP</u></b>): High coal prices are driving the company’s revenue and profit margins.</li><li><b>AdvanSix</b> (<b><u>ASIX</u></b>): You may not know this company, but you’ve probably benefited from at least one of its products.</li><li><b>Atkore</b> (<b><u>ATKR</u></b>): The company closed six acquisitions so far this year valued at a total of $310 million.</li></ul><p><img src=\"https://investorplace.com/wp-content/uploads/2019/07/large-cap-small-cap-energy-stocks-768x432.jpg\" tg-width=\"768\" tg-height=\"432\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Source: Shutterstock</p><p>If you’re an investor, you can’t afford to overlook small-cap stocks to buy.</p><p>Small-cap stocks don’t get the same kind of publicity as their mega-cap siblings. They aren’t going to lead a segment on CNBC or the home page of the <i>Wall Street Journal</i> on a daily basis. With market capitalizations ranging from around $300 million to $2 billion, small-cap stocks tend to fly under the radar.</p><p>But some of these are solid companies and excellent small-cap stocks to buy. They can inflate your portfolio just as well as a mega-cap – a 15% return in a small-cap stock is just as good as a 15% return anywhere else, right?</p><p>Because these seven small-cap stocks to buy are not as well-known, you have a greater opportunity to find those that may be underappreciated. That’s where the Portfolio Grader comes in – my exclusive free tool that evaluates stocks with a letter grade, based on both buying momentum and qualitative metrics.</p><table border=\"1\"><tbody><tr><td><b>ENPH</b></td><td><b>Enphase Energy</b></td><td>$299.34</td></tr><tr><td><b>ACLS</b></td><td><b>Axcelis Technologies</b></td><td>$61.39</td></tr><tr><td><b>AMN</b></td><td><b>Healthcare</b></td><td>$126.01</td></tr><tr><td><b>AOSL</b></td><td><b>Alpha and Omega Semiconductor</b></td><td>$32.29</td></tr><tr><td><b>ARLP</b></td><td><b>Alliance Resource Partners</b></td><td>$23.96</td></tr><tr><td><b>ASIX</b></td><td><b>AdvanSix</b></td><td>$35.73</td></tr><tr><td><b>ATKR</b></td><td><b>Atkore</b></td><td>$94.20</td></tr></tbody></table><h2>Enphase Energy (ENPH)</h2><p><b>Enphase Energy</b> (NASDAQ:<b>ENPH</b>) makes solar energy inverters and battery storage products. Customers can install the company’s microinverters on their homes, store gathered power on a battery and use it to power their homes during a service interruption.</p><p>A smartphone app allows customers to see how much power they have stored, and direct power to essential appliances when a grid outage occurs.</p><p>So far this year, Wall Street is a big fan. Even though the greater stock market is in the red, ENPH stock is up nearly 30% on the year, and it still appears to have more room to go. Analysts have a consensus price target of $310, which gives ENPH stock another 7% of projected growth.</p><p>Enphase also consistently beats expectations with its quarterly earnings reports, and Q3 was no different. Revenue of $634.71 million topped expectations of $615.85 million; earnings per share of $1.25 was better than expectation of $1.09, making this one of the small-cap stocks to buy on continued growth expectations.</p><p>ENPH stock appears to have a bright future, and has an “A” rating in the Portfolio Grader.</p><h2>Axcelis Technologies (ACLS)</h2><p><b>Axcelis Technologies</b> (NASDAQ:<b>ACLS</b>) hasn’t fared so well, but that’s to be expected considering that tech stocks in general are having a bad year. So far in 2022, ACLS stock is down by 23%, but I’m not worried.</p><p>Axcelis makes and sells next-generation Purion platforms with ion implanter technology that’s used to make semiconductors. The Purion platform helps semiconductor companies optimize their yields and reduce glitches in production.</p><p>Semiconductors have been in the news all year as a combination of Covid shutdowns, a huge demand for gaming consoles and other electronics and supply chain disruptions combined to create a huge shortage in semiconductors over the last year. While that shortage is starting to ease, it’s clear that the demand for semiconductors – and companies like Axcelis – will continue to be high.</p><p>Earnings for the second quarter topped expectations on top and bottom lines. Revenue was $221.18 million, beating expectations of $214.36 million. EPS of $1.32 was better than expectations of $1.04 per share.</p><p>ACLS will report Q3 earnings on Nov. 3. The stock has an “A” rating in my Portfolio Grader.</p><h2>AMN Healthcare (AMN)</h2><p>With baby boomers entering their twilight years and Generation X graying rapidly, the need for health care is greater than ever. <b>AMN Healthcare</b> (NYSE:<b>AMN</b>) is a leading provider of nursing staffing services for hospitals and healthcare facilities.</p><p>With more than 500 clients, AMN provides travel nurses, rapid response healthcare, staffing for schools and internationally. Those services look to be in demand. AMN estimates that a half million registered nurses will retire by the end of this year. It also estimates that there will be a shortage of 139,000 doctors in the U.S. by 2033.</p><p>Business so far is good: revenue for Q2 was $1.43 billion, beating expectations for $1.37 million. EPS of $3.31 beat expectations of $2.99 per share.</p><p>AMN is roughly flat for the year, but reports Q3 earnings on Nov. 3. It has an “A” rating in the Portfolio Grader.</p><h2>Alpha and Omega Semiconductor (AOSL)</h2><p><b>Alpha and Omega Semiconductor</b> (NASDAQ:<b>AOSL</b>) makes products that are used in flat-panel TVs, LED lighting, smartphones, battery packs, computer equipment and telecommunications equipment.</p><p>Its most recent product, a smart motor module that is purportedly the smallest in the industry, powers PC and server fans, seat cooling and home appliances.</p><p>So far this year, the stock is down 47% but it appears ripe for a turnaround as the company plans to report fiscal Q1 2023 earnings on Nov. 3. The company has been a consistent winner with its last few earnings reports, including a Q4 report with top- and bottom-line beats of $194.96 million and earnings of 95 cents per share.</p><p>AOSL stock has a “B” rating in the Portfolio Grader.</p><h2>Alliance Resource Partners (ARLP)</h2><p>There are two reasons to like <b>Alliance Resource Partners</b> (NASDAQ:<b>ARLP</b>) as a great small-cap stock.</p><p>First is its position in coal – ARLP is a top coal producers in the eastern U.S. Coal is still an important source of energy for millions of people, even as the nation begins is slow shift to alternative and cleaner energy sources.</p><p>High coal prices are driving the company’s revenue and profit margins. Alliance announced that it sold 9.185 million tons of coal in the quarter ending Sept. 30 at an average price of $59.94, compared to a year ago when it sold 8.494 million tons at an average price of just $42.65 per ton.</p><p>But this is no one-trick pony. Alliance is also working to diversify its business by investing in EV charging station company <b>Francis</b> as well as electric motor manufacturer <b>Infinitum Electric</b>.</p><p>The master limited partnership’s stock is up 90% so far in 2022, and it has an “A” rating in the Portfolio Grader.</p><h2>AdvanSix (ASIX)</h2><p>You may not be aware of <b>AdvanSix</b> (NYSE:<b>ASIX</b>), but don’t be surprised if you’ve benefited from one of its products. The chemical manufacturer produces nylon resin, which is used in products ranging from carpeting to food packaging to plastics and paint products.</p><p>AdvanSix is also the world’s biggest single-site producer of ammonium sulfate fertilizer, which is a good place to invest considering that the Earth holds 8 billion people and needs strong crop yields to feed them.</p><p>Earnings for the second quarter were a mixed bag, with revenue of $583.74 million beating expectations of $557.5 million, but EPS of $2.30 falling nine cents short of analysts’ estimates.</p><p>Wall Street will be looking for a little better when AdvanSix reports third-quarter earnings on Nov. 4. For now, it has a “B” rating in the Portfolio Grader.</p><h2>Atkore (ATKR)</h2><p><b>Atkore</b> (NYSE:<b>ATKR</b>) manufactures and sells an assortment of electrical and mechanical products – things like cable management, conduit, PVC and metal tubes, cable systems, razor wire and safety products.</p><p>And the company is expanding. It completed a total of six acquisitions to expand its footprint in 2022 with deals totaling $310 million.</p><p>Atkore stock is down 16% so far this year, but it’s making a late charge, rising by 20% just over the last month. Quarterly earnings are also helping to boost the stock’s Portfolio Grader rating, as the company consistently tops expectations in both revenue and EPS. In the third quarter, revenue of $1.06 million was better than the $1.01 billion Wall Street expected, and EPS of $6.07 beat expectations of $5.22 per share.</p><p>Atkore stock has a “B” rating in the Portfolio Grader.</p></body></html>","source":"investorplace","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Excellent Small-Cap Stocks to Buy Before This Year Ends</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Excellent Small-Cap Stocks to Buy Before This Year Ends\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-06 10:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/11/7-excellent-small-cap-stocks-to-buy-before-this-year-ends/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Some small-cap stocks tend to fly under the radar, but they still can deliver returns that rival any of their bigger-name competitors.Enphase Energy (ENPH): The California-based solar energy company ...</p>\n\n<a href=\"https://investorplace.com/2022/11/7-excellent-small-cap-stocks-to-buy-before-this-year-ends/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4147":"半导体设备","ASIX":"AdvanSix Inc.","BK4196":"保健护理服务","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","BK4141":"半导体产品","PSQ":"纳指反向ETF","LU1548497426.USD":"安联环球人工智能AT Acc","BK4156":"煤与消费用燃料","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","ACLS":"Axcelis科技设计公司","BK4090":"商品化工","TQQQ":"纳指三倍做多ETF","BK4096":"电气部件与设备","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","AOSL":"阿尔法和欧米伽半导体","ATKR":"Atkore Inc.","ARLP":"Alliance Resource Partners","ENPH":"Enphase Energy","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","AMN":"AMN医疗服务","LU0566484027.USD":"安本美国小盘成长股","LU0082616367.USD":"摩根大通美国科技A（dist）","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","SQQQ":"纳指三倍做空ETF","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H"},"source_url":"https://investorplace.com/2022/11/7-excellent-small-cap-stocks-to-buy-before-this-year-ends/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2281568031","content_text":"Some small-cap stocks tend to fly under the radar, but they still can deliver returns that rival any of their bigger-name competitors.Enphase Energy (ENPH): The California-based solar energy company consistently beats expectations in its quarterly earnings report.Axcelis Technologies (ACLS): Semiconductors will continue to be in great demand, which bodes well for Axcelis.AMN Healthcare (AMN): This company helps hospitals and healthcare facilities solve their staffing shortages.Alpha and Omega Semiconductor (AOSL): The stock is down so far in 2022, but it appears ripe for a turnaround.Alliance Resource Partners (ARLP): High coal prices are driving the company’s revenue and profit margins.AdvanSix (ASIX): You may not know this company, but you’ve probably benefited from at least one of its products.Atkore (ATKR): The company closed six acquisitions so far this year valued at a total of $310 million.Source: ShutterstockIf you’re an investor, you can’t afford to overlook small-cap stocks to buy.Small-cap stocks don’t get the same kind of publicity as their mega-cap siblings. They aren’t going to lead a segment on CNBC or the home page of the Wall Street Journal on a daily basis. With market capitalizations ranging from around $300 million to $2 billion, small-cap stocks tend to fly under the radar.But some of these are solid companies and excellent small-cap stocks to buy. They can inflate your portfolio just as well as a mega-cap – a 15% return in a small-cap stock is just as good as a 15% return anywhere else, right?Because these seven small-cap stocks to buy are not as well-known, you have a greater opportunity to find those that may be underappreciated. That’s where the Portfolio Grader comes in – my exclusive free tool that evaluates stocks with a letter grade, based on both buying momentum and qualitative metrics.ENPHEnphase Energy$299.34ACLSAxcelis Technologies$61.39AMNHealthcare$126.01AOSLAlpha and Omega Semiconductor$32.29ARLPAlliance Resource Partners$23.96ASIXAdvanSix$35.73ATKRAtkore$94.20Enphase Energy (ENPH)Enphase Energy (NASDAQ:ENPH) makes solar energy inverters and battery storage products. Customers can install the company’s microinverters on their homes, store gathered power on a battery and use it to power their homes during a service interruption.A smartphone app allows customers to see how much power they have stored, and direct power to essential appliances when a grid outage occurs.So far this year, Wall Street is a big fan. Even though the greater stock market is in the red, ENPH stock is up nearly 30% on the year, and it still appears to have more room to go. Analysts have a consensus price target of $310, which gives ENPH stock another 7% of projected growth.Enphase also consistently beats expectations with its quarterly earnings reports, and Q3 was no different. Revenue of $634.71 million topped expectations of $615.85 million; earnings per share of $1.25 was better than expectation of $1.09, making this one of the small-cap stocks to buy on continued growth expectations.ENPH stock appears to have a bright future, and has an “A” rating in the Portfolio Grader.Axcelis Technologies (ACLS)Axcelis Technologies (NASDAQ:ACLS) hasn’t fared so well, but that’s to be expected considering that tech stocks in general are having a bad year. So far in 2022, ACLS stock is down by 23%, but I’m not worried.Axcelis makes and sells next-generation Purion platforms with ion implanter technology that’s used to make semiconductors. The Purion platform helps semiconductor companies optimize their yields and reduce glitches in production.Semiconductors have been in the news all year as a combination of Covid shutdowns, a huge demand for gaming consoles and other electronics and supply chain disruptions combined to create a huge shortage in semiconductors over the last year. While that shortage is starting to ease, it’s clear that the demand for semiconductors – and companies like Axcelis – will continue to be high.Earnings for the second quarter topped expectations on top and bottom lines. Revenue was $221.18 million, beating expectations of $214.36 million. EPS of $1.32 was better than expectations of $1.04 per share.ACLS will report Q3 earnings on Nov. 3. The stock has an “A” rating in my Portfolio Grader.AMN Healthcare (AMN)With baby boomers entering their twilight years and Generation X graying rapidly, the need for health care is greater than ever. AMN Healthcare (NYSE:AMN) is a leading provider of nursing staffing services for hospitals and healthcare facilities.With more than 500 clients, AMN provides travel nurses, rapid response healthcare, staffing for schools and internationally. Those services look to be in demand. AMN estimates that a half million registered nurses will retire by the end of this year. It also estimates that there will be a shortage of 139,000 doctors in the U.S. by 2033.Business so far is good: revenue for Q2 was $1.43 billion, beating expectations for $1.37 million. EPS of $3.31 beat expectations of $2.99 per share.AMN is roughly flat for the year, but reports Q3 earnings on Nov. 3. It has an “A” rating in the Portfolio Grader.Alpha and Omega Semiconductor (AOSL)Alpha and Omega Semiconductor (NASDAQ:AOSL) makes products that are used in flat-panel TVs, LED lighting, smartphones, battery packs, computer equipment and telecommunications equipment.Its most recent product, a smart motor module that is purportedly the smallest in the industry, powers PC and server fans, seat cooling and home appliances.So far this year, the stock is down 47% but it appears ripe for a turnaround as the company plans to report fiscal Q1 2023 earnings on Nov. 3. The company has been a consistent winner with its last few earnings reports, including a Q4 report with top- and bottom-line beats of $194.96 million and earnings of 95 cents per share.AOSL stock has a “B” rating in the Portfolio Grader.Alliance Resource Partners (ARLP)There are two reasons to like Alliance Resource Partners (NASDAQ:ARLP) as a great small-cap stock.First is its position in coal – ARLP is a top coal producers in the eastern U.S. Coal is still an important source of energy for millions of people, even as the nation begins is slow shift to alternative and cleaner energy sources.High coal prices are driving the company’s revenue and profit margins. Alliance announced that it sold 9.185 million tons of coal in the quarter ending Sept. 30 at an average price of $59.94, compared to a year ago when it sold 8.494 million tons at an average price of just $42.65 per ton.But this is no one-trick pony. Alliance is also working to diversify its business by investing in EV charging station company Francis as well as electric motor manufacturer Infinitum Electric.The master limited partnership’s stock is up 90% so far in 2022, and it has an “A” rating in the Portfolio Grader.AdvanSix (ASIX)You may not be aware of AdvanSix (NYSE:ASIX), but don’t be surprised if you’ve benefited from one of its products. The chemical manufacturer produces nylon resin, which is used in products ranging from carpeting to food packaging to plastics and paint products.AdvanSix is also the world’s biggest single-site producer of ammonium sulfate fertilizer, which is a good place to invest considering that the Earth holds 8 billion people and needs strong crop yields to feed them.Earnings for the second quarter were a mixed bag, with revenue of $583.74 million beating expectations of $557.5 million, but EPS of $2.30 falling nine cents short of analysts’ estimates.Wall Street will be looking for a little better when AdvanSix reports third-quarter earnings on Nov. 4. For now, it has a “B” rating in the Portfolio Grader.Atkore (ATKR)Atkore (NYSE:ATKR) manufactures and sells an assortment of electrical and mechanical products – things like cable management, conduit, PVC and metal tubes, cable systems, razor wire and safety products.And the company is expanding. It completed a total of six acquisitions to expand its footprint in 2022 with deals totaling $310 million.Atkore stock is down 16% so far this year, but it’s making a late charge, rising by 20% just over the last month. Quarterly earnings are also helping to boost the stock’s Portfolio Grader rating, as the company consistently tops expectations in both revenue and EPS. In the third quarter, revenue of $1.06 million was better than the $1.01 billion Wall Street expected, and EPS of $6.07 beat expectations of $5.22 per share.Atkore stock has a “B” rating in the Portfolio Grader.","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}